Evidence map›Paper›PMID 39288751›Full record

ArticleThe American journal of tropical medicine and hygiene2024

Rocky Mountain Spotted Fever in Mexico: A Call to Action.

Gerardo Álvarez-Hernández, Ruy López-Ridaura, Ricardo Cortés-Alcalá, Gabriel García Rodríguez, J R Tadeo Calleja-López, Cristian N Rivera-Rosas, José Luis Alomía-Zegarra, Maureen Brophy, Carina Berenice Brito-Lorán, Maria Del Carmen Candia-Plata and 21 more

Abstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Infection and immunity · 2025
    Article
  6. Control ofInfectious Disease Modelling · 2025
    Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Gerardo Álvarez-HernándezDepartamento de Medicina y Ciencias de la Salud, Universidad de Sonora, Hermosillo, Mexico.
Ruy López-RidauraSubsecretaría de Prevención y Promoción de la Salud, Secretaría de Salud, Ciudad de México, Mexico.
Ricardo Cortés-AlcaláCentro Nacional de Programas Preventivos y Control de Enfermedades, Secretaría de Salud, Ciudad de México, Mexico.
Gabriel García RodríguezDirección General de Epidemiología, Secretaría de Salud, Ciudad de México, Mexico.
J R Tadeo Calleja-LópezDepartamento de Medicina y Ciencias de la Salud, Universidad de Sonora, Hermosillo, Mexico.
Cristian N Rivera-RosasDepartamento de Medicina y Ciencias de la Salud, Universidad de Sonora, Hermosillo, Mexico.
José Luis Alomía-ZegarraSecretaría de Salud Pública del Estado de Sonora, Hermosillo, Mexico.
Maureen BrophyNational Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Carina Berenice Brito-LoránInstituto Nacional de Diagnóstico y Referencia Epidemiológicos (InDRE) "Dr. Manuel Martínez Báez," Secretaría de Salud, Ciudad de México, Mexico.
Maria Del Carmen Candia-PlataDepartamento de Medicina y Ciencias de la Salud, Universidad de Sonora, Hermosillo, Mexico.
Santa Elizabeth Ceballos-LiceagaDirección General de Epidemiología, Secretaría de Salud, Ciudad de México, Mexico.
Fabián Correa-MoralesCentro Nacional de Programas Preventivos y Control de Enfermedades, Secretaría de Salud, Ciudad de México, Mexico.
Karla R Dzul-RosadoCentro de Investigaciones Regionales "Dr. Hideyo Noguchi," Universidad Autónoma de Yucatán, Mérida, Mexico.
Janet FoleyDepartment of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, California.
José Manuel Galván-MoroyoquiDepartamento de Medicina y Ciencias de la Salud, Universidad de Sonora, Hermosillo, Mexico.
Roman GantaDepartment of Veterinary Pathobiology, College of Veterinary Medicine, University of Missouri, Columbia, Missouri.
Verónica Gutiérrez-CedilloCentro Nacional de Programas Preventivos y Control de Enfermedades, Secretaría de Salud, Ciudad de México, Mexico.
Néstor Saúl Hernández-MilánSecretaría de Salud del Estado de Baja California, Mexicali, Mexico.
Andrés M López-PérezRed de Biología y Conservación de Vertebrados, Instituto de Ecología, Xalapa, Mexico.
Luis Fernando López-SotoDepartamento de Medicina y Ciencias de la Salud, Universidad de Sonora, Hermosillo, Mexico.
Juan Manuel Martínez-SotoDepartamento de Medicina y Ciencias de la Salud, Universidad de Sonora, Hermosillo, Mexico.
Ana Lourdes Mata-PinedaDepartamento de Medicina y Ciencias de la Salud, Universidad de Sonora, Hermosillo, Mexico.
Christopher D PaddockNational Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Irma Leticia J Ruiz-GonzálezSecretaría de Salud del Estado de Chihuahua, Chihuahua, Mexico.
Juan Edmundo Salinas-AguirreSecretaría de Salud del Estado de Coahuila, Saltillo, Mexico.
Johanna S SalzerNational Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Sokani Sánchez-MontesFacultad de Ciencias Biológicas y Agrícolas, Región Poza Rica-Tuxpan, Universidad Veracruzana, Tuxpan de Rodríguez Cano, Mexico.
Adriana Soto-GuzmánDepartamento de Medicina y Ciencias de la Salud, Universidad de Sonora, Hermosillo, Mexico.
Óscar Tamez-RiveraTecnológico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Monterrey, Mexico.
David M WagnerNorthern Arizona University, Flagstaff, Arizona.
David H WalkerDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas.

Funding

Rocky Mountain Spotted Fever Vaccine DevelopmentR01AI152417 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI ROMAN R. GANTA · 2021 to 2026
$3.7M
NIAID NIH HHS R01 AI152417
6 · The paper itself

Abstract

Rocky Mountain spotted fever (RMSF) is an ongoing public health crisis in Mexico, particularly in states bordering the United States. The national highest incidence and mortality of RMSF occur in this region, resulting in a case-fatality rate that ranges annually between 10% and 50%, primarily affecting vulnerable groups such as children, elderly adults, and persons living in poverty. Multiple biological, environmental, and social determinants can explain its growing presence throughout the country and how it challenges the health system and society. It is necessary to integrate resources and capacities from health authorities, research centers, and society to succeed in dealing with this problem. Through a scientific symposium, a group of academicians, U.S. health officials, and Mexican health authorities met on November 8-10, 2023, in Hermosillo, Mexico, to discuss the current situation of RMSF across the country and the challenges associated with its occurrence. An urgent call for action to improve national capacity against RMSF in the aspects of epidemiological and acarological surveillance, diagnosis, medical care, case and outbreak prevention, health promotion, and research was urged by the experts. The One Health approach is a proven multidisciplinary strategy to integrate policies and interventions to mitigate and prevent the burden of cases, deaths, and suffering caused by RMSF in Mexico.

Indexed as

Rocky Mountain Spotted FeverDisease OutbreaksHumansIncidenceMexicoPublic Health

Identifiers

PMID39288751
PMCPMC11542536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.